Sponsor:
Vanderbilt University Medical Center
Code:
NCT03312556
Conditions
Supine Hypertension
Autonomic Failure
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
continuous positive airway pressure (CPAP)
Placebo
Brief summary:
Conditions
Supine Hypertension
Autonomic Failure
Study ID
NCT03312556
Start date
Sep 21, 2017
Status verified date
Nov, 2025
Completion date
Dec 21, 2026
Anticipated
Primary completion date
Sep 21, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
12 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
placebo comparator: Placebo pill or patch or sham CPAP
active comparator: CPAP (continuous positive airway pressure)
Interventions
continuous positive airway pressure (CPAP)
Placebo
Primary outcome measure
Central contacts
Locations
Autonomic Dysfunction Center/ Vanderbilt University Medical Center
Recruiting
Nashville, Tennessee, United States, 37232
Contacts
Principal Investigator:
Italo Biaggioni, MD
Sponsor
Vanderbilt University Medical Center
Last update posted
Nov 6, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2025-11-06.